Faraday Pharmaceuticals Announces First Patient Enrolled in Phase 2 Study for ICU-Acquired Weakness

NEXT STORY
Worldwide Artificial Disc Replacement Industry to 2026 – Increasing Funding from Governments and Regulatory Bodies Presents Opportunities
PREV STORY
Global Biologics Industry Forecast, 2026: Opportunities, Trends, Regulations, and Profiles of Major Competitors such as AbbVie, Amgen, and Roche
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Junshi Biosciences Announces Full Year 2020 Financial Results And Provides Corporate Updates

author_avatar
NASDAQ Market News

Jounce Therapeutics to Announce Third Quarter 2019 Financial Results and Host Conference Call on Thursday, November 7, 2019

author_avatar
NASDAQ Market News

Data from Long-Term Safety Study Support Chronic Use of ARQ-151 (Topical Roflumilast Cream) as a Potential Treatment for Plaque Psoriasis

author_avatar
NASDAQ Market News